Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Females”

4,148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,148 results

Early research (Phase 1)Study completedNCT02876627
What this trial is testing

Effect Aerobic Training on Women With Breast Cancer After Chemotherapy

Who this might be right for
CancerExerciseHemoglobins
University of Isfahan 30
Not applicableActive Not RecruitingNCT05708703
What this trial is testing

Assessing the Time Demands of Cancer

Who this might be right for
Metastatic Breast CancerOvarian Cancer
Masonic Cancer Center, University of Minnesota 78
Large-scale testing (Phase 3)Study completedNCT03753776
What this trial is testing

Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women

Who this might be right for
Breast Cancer
Centre Hospitalier Universitaire de Saint Etienne 232
Testing effectiveness (Phase 2)UnknownNCT01266213
What this trial is testing

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

Who this might be right for
Metastatic Breast CancerEstrogen Receptor Positive TumorBreast Cancer Nos Premenopausal
Samsung Medical Center 147
Early research (Phase 1)Ended earlyNCT00972023
What this trial is testing

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 1
Testing effectiveness (Phase 2)Study completedNCT03665285
What this trial is testing

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more
NextCure, Inc. 109
Large-scale testing (Phase 3)Study completedNCT00390455
What this trial is testing

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Who this might be right for
Estrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more
National Cancer Institute (NCI) 295
Post-approval studies (Phase 4)Ended earlyNCT04031885
What this trial is testing

Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 4
Not applicableStudy completedNCT07071415
What this trial is testing

Overdiagnosis and Breast Cancer Screening Decisions

Who this might be right for
Mammography ScreeningGeriatricsDecision Aid
Yale University 311
Early research (Phase 1)Active Not RecruitingNCT04188548
What this trial is testing

LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer+1 more
Eli Lilly and Company 500
Testing effectiveness (Phase 2)Study completedNCT00003540
What this trial is testing

Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 30
Not applicableStudy completedNCT04343820
What this trial is testing

Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec)

Who this might be right for
Breast Cancer Female
Institut Cancerologie de l'Ouest 60
Testing effectiveness (Phase 2)UnknownNCT04318223
What this trial is testing

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast Cancer
Consorzio Oncotech 168
Not applicableStudy completedNCT05760755
What this trial is testing

Stick Together - Pilot Intervention Study

Who this might be right for
Breast Cancer Female
Rigshospitalet, Denmark 44
Testing effectiveness (Phase 2)Study completedNCT00755885
What this trial is testing

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK 77
Very early researchStudy completedNCT03832985
What this trial is testing

Pediatric Reporting of Adult-Onset Genomic Results

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeLynch SyndromeFamilial Hypercholesterolemia
Geisinger Clinic 162
Not applicableTemporarily pausedNCT03547089
What this trial is testing

A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes

Who this might be right for
Vaginal AtrophyGenitourinary System; Disorder, FemaleVaginal Abnormality+2 more
W. Grant Stevens, MD 10
Testing effectiveness (Phase 2)Study completedNCT00675259
What this trial is testing

Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 33
Very early researchStudy completedNCT01434342
What this trial is testing

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Who this might be right for
Lung CancerTobacco Use DisorderBreast Cancer+2 more
Wake Forest University Health Sciences 146
Not applicableLooking for participantsNCT03788213
What this trial is testing

One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer

Who this might be right for
Breast Cancer Female
Tata Medical Center 2,100
Load More Results